Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of … – PR Newswire (press release)
December 23rd, 2009
Alimera Announces Positive Results From the Two Phase 3 FAME(TM) Trials of …PR Newswire (press release)Alimera's initial focus is on the use of NADPH oxidase inhibitors in the treatment of the dry form of age-related macular degeneration (AMD), …
Original post by macular degeneration – Google News
(click on the author/publication link above to see full post)